LIH is currently refining its research strategy to focus more on translational research, placing patients and the population at the centre of its activities. Jointly with its national partners, the institute aims to develop new diagnostic methods, innovative therapies and effective tools to contribute to the implementation of personalised medicine. In this context, Prof Rejko Krüger has joined LIH as Director of Transversal Translational Medicine while continuing his commitments at the University of Luxembourg and the Centre Hospitalier de Luxembourg (CHL). Furthermore, Dr Guy Berchem has been appointed Associated Medical Director and Prof Simone Niclou has taken over the management of the Department of Oncology. 

Find out more here